Seyed Latif Mousavi Gargari Selected Research

Carbonic Anhydrase IX

1/2014

A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seyed Latif Mousavi Gargari Research Topics

Disease

12	Infections 01/2024 - 12/2011
7	Neoplasms (Cancer) 01/2024 - 01/2014
4	Burns 01/2024 - 12/2019
3	Pneumonia (Pneumonitis) 01/2024 - 12/2019
3	Wounds and Injuries (Trauma) 01/2024 - 12/2019
3	Pseudomonas Infections 01/2021 - 12/2019
2	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2023
2	Cholera 09/2018 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 07/2016
1	Triple Negative Breast Neoplasms 01/2023
1	Bacterial Meningitis 11/2022
1	Meningitis 11/2022
1	Diarrhea 09/2021
1	Neoplasm Metastasis (Metastasis) 08/2020
1	Neutropenia 08/2020
1	Crimean Hemorrhagic Fever 11/2019
1	Hypoxia (Hypoxemia) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Botulism 10/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2011
6	AntibodiesIBA 01/2024 - 01/2017
5	VaccinesIBA 01/2024 - 01/2018
4	IgYIBA 02/2023 - 12/2019
3	AntigensIBA 08/2021 - 07/2016
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2024 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2024 - 02/2017
2	Single-Stranded DNA (DNA, Single Stranded)IBA 11/2022 - 07/2016
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2024
1	CytokinesIBA 01/2024
1	Cancer VaccinesIBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 01/2024
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Toll-Like Receptor AgonistsIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	EnzymesIBA 11/2022
1	OligonucleotidesIBA 11/2022
1	Shiga Toxins (Vero Toxin)IBA 09/2022
1	FlagellinIBA 01/2021
1	flaB flagellinIBA 01/2021
1	ChemokinesIBA 08/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2020
1	OmpF proteinIBA 01/2020
1	IronIBA 12/2019
1	siderophore receptorsIBA 12/2019
1	NucleoproteinsIBA 11/2019
1	Antiviral Agents (Antivirals)IBA 11/2019
1	Cholera Vaccines FDA Link 01/2018
1	ChitosanIBA 01/2017
1	Glutaral (Glutaraldehyde)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	NanogelsIBA 01/2017
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2017
1	APTIBA 01/2017
1	Single-Domain AntibodiesIBA 01/2017
1	Nucleotide AptamersIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2014
1	Immunodominant EpitopesIBA 12/2014
1	Carbonic Anhydrase IXIBA 01/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2014
1	AntitoxinsIBA 10/2013
1	Immunoglobulins (Immunoglobulin)IBA 10/2013
1	Botulinum Toxins (Botulinum Toxin)IBA 10/2013

Therapy/Procedure

5	Immunotherapy 01/2024 - 01/2017
3	Therapeutics 01/2024 - 01/2017
2	Drug Therapy (Chemotherapy) 08/2020 - 01/2017
1	Subcutaneous Injections 01/2020
1	Radiotherapy 01/2017